LabMed

Elevated Platelet Count

Differential Diagnosis

Essential thrombocythemia with platelet count typically greater than 600,000/µL

Reactive thrombocytosis from:

  • inflammation

  • infection

  • malignancy

  • iron deficiency anemia

  • acute blood loss

  • rebound from marrow suppression or immune thrombocytopenia

  • post-splenectomy

Dangerous Situations

Platelet counts greater than 1,000,000/µL are worrisome for acute thrombotic events.

Elevated platelet count with poorly functioning platelets does not present an increased risk for thrombosis.

Commonly Encountered Situations

Reactive thrombocytosis from a variety of causes is far more common than essential thrombocythemia (a chronic myeloproliferative disorder).

Suggested Additional Lab Testing

Test that reveals any of the causes of reactive thrombocytosis previously noted are valuable.

Tests to confirm the presence of essential thrombocythemia include:

  • bone marrow biopsy to show an increase in the number of megakaryocytes

  • normal RBC mass to exclude polycythemia vera

  • platelet aggregation study showing a selective impaired aggregation response only to epinephrine suggests essential thrombocythemia

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters